...
首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Higti-dose corticosterooe after fear conditioning selectively suppresses fear renewal by reducing anxiety-like response
【24h】

Higti-dose corticosterooe after fear conditioning selectively suppresses fear renewal by reducing anxiety-like response

机译:恐惧适应后的半剂量皮质类固醇通过减少焦虑样反应选择性地抑制恐惧更新

获取原文
获取原文并翻译 | 示例

摘要

Exposure therapy is widely used to treat anxiety disorders, including posttraumatic stress disorder (PTSD). However, preventing the return of fear is still a major challenge after this behavioral treatment. An increasing number of studies suggest that high-dose glucocorticoid treatment immediately after trauma can alleviate the symptoms of PTSD in humans. Unknown is whether high-dose glucocorticoid treatment following fear conditioning suppresses the return of fear. In the present study, a typical fear renewal paradigm (MB) was used, in which the fear response to an auditory cue can be restored in a novel context (context B) when both training and extinction occur in the same context (context A). We trained rats for auditory fear conditioning and administered corticosterone (CORT; 5 and 25 mg/kg, i.p.) or vehicle with different delays (1 and 24 h).
机译:暴露疗法被广泛用于治疗焦虑症,包括创伤后应激障碍(PTSD)。然而,在这种行为治疗之后,防止恐惧的再次发生仍然是一个重大挑战。越来越多的研究表明,创伤后立即进行大剂量糖皮质激素治疗可以缓解人的PTSD症状。尚不清楚的是恐惧调节后的大剂量糖皮质激素治疗是否能抑制恐惧的复发。在本研究中,使用了一种典型的恐惧更新范例(MB),其中当训练和消亡都发生在同一上下文中时(上下文A),可以在一个新的上下文中恢复对听觉提示的恐惧反应(上下文B)。 。我们对大鼠进行听觉恐惧条件训练,并以不同的延迟时间(1和24小时)给予皮质酮(CORT; 5和25 mg / kg,腹腔注射)或赋形剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号